MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 5, 2005; DOI: 10.1124/mol.104.006437


0026-895X/05/6704-1221-1228$20.00
Mol Pharmacol 67:1221-1228, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.006437v1
67/4/1221    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barberis, A.
Right arrow Articles by Mozrzymas, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barberis, A.
Right arrow Articles by Mozrzymas, J. W.
Original Article

Developmental Changes of GABA Synaptic Transient in Cerebellar Granule Cells

Andrea Barberis, Congyi Lu, Stefano Vicini, and Jerzy W. Mozrzymas

Department of Physiology and Biophysics, Georgetown University School of Medicine, Washington, DC (A.B., C.L., S.V., J.W.M.); and Laboratory of Neuroscience, Department of Biophysics, Wroclaw Medical University, Wroclaw, Poland (J.W.M.)

Abstract

The time course of synaptic currents is largely determined by the microscopic gating of the postsynaptic receptors and the temporal profile of the synaptic neurotransmitter concentration. Although several lines of evidence indicate that developmental changes of GABAergic synaptic current time course are clearly correlated with a switch in postsynaptic receptors, much less is known about the modification of GABA release during development. To address this issue, we studied the sensitivity of miniature inhibitory postsynaptic currents (mIPSCs) to a quickly dissociating competitive antagonist, 1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid (TPMPA), in neurons cultured for 6 to 8 days in vitro (DIV) ("young") and for 12 to 14 DIV ("old"). mIPSCs recorded in young neurons were significantly more resistant to the block by TPMPA. This observation was interpreted as a consequence of a more efficient displacement of TPMPA from GABAA receptors caused by a stronger GABA release in young neurons. The change in mIPSC sensitivity to TPMPA during development was not affected by the deletion of {alpha}1 subunit, supporting its presynaptic origin. The effects of a second quickly dissociating antagonist, SR-95103 [2-(carboxy-3'-propyl)-3-amino-4-methyl-6-phenylpyridazinium chloride], on young, old, and {alpha}1 -/- neurons were qualitatively the same as those obtained with TPMPA. Moreover, the analysis of current responses to ultrafast GABA applications showed that the unbinding rates of TPMPA in DIV 6 to 8 and in DIV 12 to 14 neurons are not significantly different, ruling out the postsynaptic mechanism of differential TPMPA action. Thus, we provide evidence that presynaptic GABA uniquantal release is developmentally regulated.


Received August 19, 2004; accepted January 5, 2005

Address correspondence to: Dr. Andrea Barberis, Department of Physiology and Biophysics, Georgetown University School of Medicine, 225 Basic Research Bldg. 3900 Reservoir Rd., NW, Washington, DC 20007. E-mail: barberis{at}sissa.it




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Szabadics, G. Tamas, and I. Soltesz
Different transmitter transients underlie presynaptic cell type specificity of GABAA,slow and GABAA,fast
PNAS, September 11, 2007; 104(37): 14831 - 14836.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics